Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 10
Submit an article Journal homepage
794
Views
26
CrossRef citations to date
0
Altmetric
Reviews

Medical treatment of vestibular disorders

Thomas Brandt Ludwig-Maximilians-University, Institute of Clinical Neuroscience, Marchioninistr. 15, 81377 Munich, Germany +49 89 7095 2380 1; +49 89 7095 8855; [email protected]
, MD FRCP,
Andreas Zwergal Ludwig-Maximilians-University, Institute of Clinical Neuroscience, Marchioninistr. 15, 81377 Munich, Germany +49 89 7095 2380 1; +49 89 7095 8855; [email protected]
, MD &
Michael Strupp Ludwig-Maximilians-University, Institute of Clinical Neuroscience, Marchioninistr. 15, 81377 Munich, Germany +49 89 7095 2380 1; +49 89 7095 8855; [email protected]
, MD
Pages 1537-1548 | Published online: 15 Jun 2009

Bibliography

  • Neuhauser H, von Brevern M, Radtke A, et al. Epidemiology of vestibular vertigo: a neurootologic survey of the general population. Neurology 2005;65:898-904
  • Brandt T, Dieterich M, Strupp M. Vertigo and dizziness: common complaints. London: Springer, 2005
  • Sekitani T, Imate Y, Noguchi T, et al. Vestibular neuronitis: epidemiological survey by questionnaire in Japan. Acta Otolaryngol 1993;503(Suppl):9-12
  • Schulz P, Arbusow V, Strupp M, et al. Highly variable distribution of HSV-1-specific DNA in human geniculate, vestibular and spiral ganglia. Neurosci Lett 1998;252:139-42
  • Arbusow V, Schulz P, Strupp M, et al. Distribution of herpes simplex virus type 1 in human geniculate and vestibular ganglia: implications for vestibular neuritis. Ann Neurol 1999;46:416-9
  • Arbusow V, Theil D, Strupp M, et al. HSV-1 not only in human vestibular ganglia but also in the vestibular labyrinth. Audiol Neurootol 2000;6:259-62
  • Theil D, Arbusow V, Derfuss T, et al. Prevalence of HSV-1 lat in human trigeminal, geniculate, and vestibular ganglia and its implication for cranial nerve syndromes. Brain Pathol 2000;11:408-13
  • Theil D, Derfuss T, Strupp M, et al. Cranial nerve palsies: herpes simplex virus type 1 and varizella-zoster virus latency. Ann Neurol 2002;51:273-4
  • Theil D, Derfuss T, Paripovic I, et al. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol 2003;163:2179-84
  • Strupp M, Zingler VC, Arbusow V, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 2004;351:354-61
  • Shupak A, Ussa A, Golz A, et al. Prednisone treatment for vestibular neuritis. Otol Neurotol 2008;29:368-74
  • Havia M, Kentala E, Pyykkö I. Prevalence of Menière's disease in general population of Southern Finland. Otolaryngol Head Neck Surg 2005;133:762-8
  • Neuhauser H. Epidemiology of vertigo. Curr Opin Neurol 2007;20:40-6
  • Minor LB, Schessel DA, Carey JP. Menière's disease. Curr Opin Neurol 2004;17:9-16
  • Yeh TH, Herman P, Tsai MC, et al. A cationic nonselective stretch-activated channel in the Reissner's membrane of the guinea pig cochlea. Am J Physiol 1998;274:C566-76
  • van-Deelen GW, Huizing EH. Use of a diuretic (Dyazide) in the treatment of Menière's disease. A double-blind cross-over placebo-controlled study. ORL J Otorhinolaryngol Relat Spec 1986;48:287-92
  • Smith WK, Sankar V, Pfleiderer AG. A national survey amongst UK otolaryngologists regarding the treatment of Menière's disease. J Laryngol Otol 2005;119:102-5
  • Magnusson M, Padoan S, Karlberg M, et al. Delayed onset of ototoxic effects of gentamicin in patients with Menière's disease. Acta Otolaryngol Suppl Stockh 1991;485:120-2
  • Lange G, Maurer J, Mann W. Long-term results after interval therapy with intratympanic gentamicin for Meniere's disease. Laryngoscope 2004;114:102-5
  • Cohen-Kerem R, Kisilevsky V, Einarson TR, et al. Intratympanic gentamicin for Meniere's disease: a meta-analysis. Laryngoscope 2004;114:2085-91
  • Carey JP, Hirvonen T, Peng GC, et al. Changes in the angular vestibulo-ocular reflex after a single dose of intratympanic gentamicin for Meniere's disease. Auris Nasus Larynx 2002;956:581-4
  • Barrs DM. Intratympanic injections of dexamethasone for long-term control of vertigo. Laryngoscope 2004;114:1910-4
  • Boleas-Aguirre MS, Lin FR, Della Santina CC, et al. Longitudinal results with intratympanic dexamethasone in the treatment of Menière's disease. Otol Neurotol 2008;29(1):33-8
  • Yilmaz I, Yilmazer C, Erkan AN, et al. Intratympanic dexamethasone injection effects on transient-evoked otoacoustic emission. Am J Otolaryngol 2005;26:113-7
  • Meyer ED. Zur Behandlung des Morbus Menière mit Betahistinmesilat (Aequamen) – Doppelblindstudie gegen Placebo (crossover). Laryng Rhinol Otol 1985;64:269-72
  • Claes J, Van-de-Heyning PH. Medical treatment of Meniere's disease: a review of literature. Acta Otolaryngol Suppl 1997;526:37-42
  • James A, Thorp M. Meniere's disease. Clin Evid 2004;12:742-50
  • Dziadziola JK, Laurikainen EL, Rachel JD, et al. Betahistine increases vestibular blood flow. Otolaryngol Head Neck Surg 1999;120:400-5
  • Strupp M, Huppert D, Frenzel C, et al. Long-term prophylactic treatment of attacks of vertigo in Menière's disease: comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol 2008;128:520-4
  • Jeck-Thole S, Wagner W. Betahistine: a retrospective synopsis of safety data. Drug Saf 2006;29:1049-59
  • James AL, Burton MJ. Betahistine for Menière's disease or syndrome. Cochrane Database Syst Rev 2001;(1):CD001873
  • Jannetta PJ. Neurovascular cross compression in patients with hyperactive dysfunction symptoms of the eighth cranial nerve. Surg Forum 1975;26:467-8
  • Jannetta PJ, Moller MB, Moller AR. Disabling positional vertigo. N Engl J Med 1984;310:1700-5
  • Moller MB, Moller AR, Jannetta PJ, et al. Microvascular decompression of the eighth nerve in patients with disabling positional vertigo: selection criteria and operative results in 207 patients. Acta Neurochir (Wien) 1993;125:75-82
  • Moller MB, Moller AR, Jannetta PJ, Sekhar L. Diagnosis and surgical treatment of disabling positional vertigo. J Neurosurg 1986;64:21-8
  • Moller MB. Results of microvascular decompression of the eighth nerve as treatment for disabling positional vertigo. Ann Otol Rhinol Laryngol 1990;99:724-9
  • Brandt T, Dieterich M. Vestibular paroxysmia: vascular compression of the eighth nerve? Lancet 1994;343:798-9
  • Ryu H, Yamamoto S, Sugiyama K, Nozue M. Neurovascular compression syndrome of the eighth cranial nerve: what are the most reliable diagnostic signs? Acta Neurochir (Wien) 1998;140:1279-86
  • Schwaber MK, Hall JW. Cochleovestibular nerve compression syndrome, I: clinical features and audiovestibular findings. Laryngoscope 1992;102:1020-9
  • Brackmann DE, Kesser BW, Day JD. Microvascular decompression of the vestibulocochlear nerve for disabling positional vertigo: the house ear clinic experience. Otol Neurotol 2001;22:882-7
  • McCabe BF, Gantz BJ. Vascular loop as a cause of incapacitating dizziness. Am J Otol 1989;10:117-20
  • Hüfner K, Barresi D, Glaser M, et al. Vestibular paroxysmia: diagnostic features and medical treatment. Neurology 2008;71:1006-14
  • Wagner JN, Glaser M, Brandt T, et al. Downbeat nystagmus: aetiology and comorbidity in 117 patients. J Neurol Neurosurg Psychiatry 2008;79:672-7
  • Leigh RJ, Zee D. The neurology of eye movements, 4th edition. Oxford, New York: Oxford University Press, 2006
  • Baloh RW, Spooner JW. Downbeat nystagmus: a type of central vestibular nystagmus. Neurology 1981;31:304-10
  • Pierrot-Deseilligny C, Milea D. Vertical nystagmus: clinical facts and hypotheses. Brain 2005;128:1237-46
  • Halmagyi GM, Rudge P, Gresty MA, et al. Downbeating nystagmus: a review of 62 cases. Arch Neurol 1983;40:777-84
  • Straumann D, Zee DS, Solomon D. Three-dimensional kinematics of ocular drift in humans with cerebellar atrophy. J Neurophysiol 2000;83:1125-40
  • Glasauer S, Hoshi M, Kempermann U, et al. Three-dimensional eye position and slow phase velocity in humans with downbeat nystagmus. J Neurophysiol 2003;89:338-54
  • Glasauer S, von LH, Siebold C, et al. Vertical vestibular responses to head impulses are symmetric in downbeat nystagmus. Neurology 2004;63:621-5
  • Glasauer S, Hoshi M, Buttner U. Smooth pursuit in patients with downbeat nystagmus. Ann NY Acad Sci 2005;1039:532-5
  • Bronstein AM, Miller DH, Rudge P, et al. Downbeating nystagmus: magnetic resonance imaging and neuro-otological findings. J Neurol Sci 1987;81:173-84
  • Zee DS, Yamazaki N, Butler PHZ, et al. Effects of ablation of flocculus and paraflocculus on eye movements in primate. J Neurophysiol 1981;46:878-99
  • Lisberger SG, Miles FA, Zee DS. Signals used to compute errors in monkey vestibuloocular reflex: possible role of flocculus. J Neurophysiol 1984;52:1140-53
  • Rambold H, Churchland A, Selig Y, et al. Partial ablations of the flocculus and ventral paraflocculus in monkeys cause linked deficits in smooth pursuit eye movements and adaptive modification of the VOR. J Neurophysiol 2002;87:912-24
  • Dieterich M, Brandt T. Vestibulo-ocular reflex. Curr Opin Neurol 1995;8:83-8
  • Bohmer A, Straumann D. Pathomechanism of mammalian downbeat nystagmus due to cerebellar lesion: a simple hypothesis. Neurosci Lett 1998;250:127-30
  • Marti S, Palla A, Straumann D. Gravity dependence of ocular drift in patients with cerebellar downbeat nystagmus. Ann Neurol 2002;52:712-21
  • Sprenger A, Rambold H, Sander T, et al. Treatment of the gravity dependence of downbeat nystagmus with 3, 4-diaminopyridine. Neurology 2006;67:905-7
  • Zee DS, Friendlich AR, Robinson DA. The mechanism of downbeat nystagmus. Arch Neurol 1974;30:227-37
  • Marti S, Straumann D, Glasauer S. The origin of downbeat nystagmus: an asymmetry in the distribution of on-directions of vertical gaze-velocity purkinje cells. Auris Nasus Larynx 2005;1039:548-53
  • Partsalis AM, Zhang Y, Highstein SM. Dorsal Y group in the squirrel monkey. II. Contribution of the cerebellar flocculus to neuronal responses in normal and adapted animals. J Neurophysiol 1995;73:632-50
  • Kalla R, Deutschlander A, Hufner K, et al. Detection of floccular hypometabolism in downbeat nystagmus by fMRI. Neurol 2006;66:281-3
  • Bense S, Best C, Buchholz HG, et al. 18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus. Neuroreport 2006;17:599-603
  • Hufner K, Stephan T, Kalla R, et al. Structural and functional MRIs disclose cerebellar pathologies in idiopathic downbeat nystagmus. Neurology 2007;69:1128-35
  • Young YH, Huang TW. Role of clonazepam in the treatment of idiopathic downbeat nystagmus. Laryngoscope 2001;111:1490-3
  • Currie JN, Matsuo V. The use of clonazepam in the treatment of nystagmus-induced oscillopsia. Ophthalmol 1986;93:924-32
  • Dieterich M, Straube A, Brandt T, et al. The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psych 1991;54:627-32
  • Averbuch-Heller L, Tusa RJ, Fuhry L, et al. A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 1997;41:818-25
  • Strupp M, Schuler O, Krafczyk S, et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 2003;61:165-70
  • Etzion Y, Grossman Y. Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells. Exp Brain Res 2001;139:419-25
  • Helmchen C, Sprenger A, Rambold H, et al. Effect of 3,4-diaminopyridine on the gravity dependence of ocular drift in downbeat nystagmus. Neurology 2004;63:752-3
  • Sprenger A, Zils E, Rambold H, et al. Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus. Ann NY Acad Sci 2005;1039:395-403
  • Kalla R, Glasauer S, Schautzer F, et al. 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain. Neurology 2004;62:1228-9
  • Kalla R, Glasauer S, Buttner U, et al. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. Brain 2007;130:2441-51
  • Glasauer S, Kalla R, Buttner U, et al. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus. J Neurol Neurosurg Psychiatry 2005;76:451-3
  • Glasauer S, Strupp M, Kalla R, et al. Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus. Ann NY Acad Sci 2005;1039:528-31
  • Cavelier P, Pouille F, Desplantez T, et al. Control of the propagation of dendritic low-threshold Ca(2 + ) spikes in Purkinje cells from rat cerebellar slice cultures. J Physiol 2002;540:57-72
  • Griggs RC, Nutt JG. Episodic ataxias as channelopathies. Ann Neurol 1995;37:285-7
  • Jen J, Kim GW, Baloh RW. Clinical spectrum of episodic ataxia type 2. Neurology 2004;62:17-22
  • Strupp M, Zwergal A, Brandt T. Episodic ataxia type 2. Neurotherapeutics 2007;4:267-73
  • Griggs RC, Moxley RT, Lafrance RA, et al. Hereditary paroxysmal ataxia: response to acetazolamide. Neurology 1978;28:1259-64
  • Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2 + channel gene CACNL1A4. Cell 1996;87:543-52
  • Kullmann DM. The neuronal channelopathies. Brain 2002;125:1177-95
  • Strupp M, Kalla R, Dichgans M, et al. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 2004;62:1623-5
  • Weisz CJ, Raike RS, Soria-Jasso LE, et al. Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering. J Neurosci 2005;25:4141-5
  • Honrubia V. Quantitative vestibular function tests and the clinical examination. In: Herdman SJ, editor, Vestibular rehabilitation, 1st edition. Philadelphia: FA Davis; 1994. p. 113-64

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.